Primrose Bio attends the 2nd Annual AMM Ascent Meeting, from September 16–18, 2025, at the Coronado Island Marriott Resort in San Diego.
On Wednesday, September 17 at 11:30 AM, Helge Zieler, PhD, CEO of Primrose Bio, presents “Beyond T7: Engineered RNA Polymerases for a New Era of mRNA Manufacturing.” In this session, he discusses how novel enzyme designs support improved mRNA quality, reduced inputs, and scalable solutions across therapeutic modalities.
Also attending from the Primrose Bio team:
- Michele Rubino, Chief Business Officer
- Jennifer Wittbold, Associate Director, Product & Business Development
- Sabrina Baffert, Director of Molecular Biology
The team engages with attendees throughout the conference to explore how Prima RNApols™, our high-performance RNA polymerases, help lower costs and improve mRNA therapeutic development from discovery to clinical scale.
